Why DUPIXENT
May Be Right for
Your Teen

DUPIXENT is a prescription medication and the first biologic approved to treat people 12 years and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. DUPIXENT can be used with or without topical corticosteroids. It is not known if DUPIXENT is safe and effective in children with atopic dermatitis under 12 years of age.

DUPIXENT is an injectible prescription medicine used by teens ages 12-17 in clinical studies. You can view the results of the clinical study, and see the results of patients who were administered DUPIXENT vs. those who received a placebo.

Treats individuals aged 12 years and older with uncontrolled moderate-to-severe atopic dermatitis (eczema)

Continuously treats your teen’s skin, even when it looks clear

Injectable prescription medicine that’s not a steroid or cream

SEE THE DATA
Actor portrayal;
individual results vary

Is Eczema Different Than Atopic Dermatitis?

There are many forms of eczema, with atopic dermatitis being the most common. Learn why what’s going on underneath your teen’s skin is just as important as what is happening on top of it. See the role inflammation plays in your teen’s symptoms.

GET THE FACTS

Let DUPIXENT MyWay® Help

There’s no question that uncontrolled moderate-to-severe atopic dermatitis can be daunting, and there are plenty of questions about how to treat it. That’s why we’ve created the DUPIXENT MyWay program. You’ll get:

  • Nurse Educators offering tips, tools, and resources
  • Supplemental injection training online or in-person
  • Ongoing nursing support for DUPIXENT available by phone 24/7
  • Help scheduling deliveries and monthly prescription refills
  • Exclusive support and resources about DUPIXENT
GET MORE INFO
Connect With a Specialist Who Treats Eczema

Consult with your teen’s doctor and then use this tool to easily find nearby specialists with experience in treating teens and adults with uncontrolled moderate-to-severe eczema (atopic dermatitis).

Are you sure you want to leave?
Please note: By clicking on this link, you will be leaving this Sanofi-hosted US website and going to another, entirely independent website. Sanofi US and Regeneron provide these links as a service to its website visitors and users; however, they take no responsibility for the information on any website but their own.

Sanofi US and Regeneron do not endorse or recommend any particular physician, and search results do not include a comprehensive list of doctors in your area.